Related Experiment Video
Updated: Jul 7, 2026

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
[Neuropathy induced by antineoplastic drugs]
Junichi Kusunoki1, Toyokazu Saito
1Department of Neurology, Kitasato University School of Medicine, 1-1-1 Kitasato, Sagamihara, Kanagawa 228 8555, Japan.
Chemotherapy for carcinoma prolongs patient life but can cause neurotoxicity. Cisplatin chemotherapy, in particular, can lead to irreversible nerve damage, requiring careful administration.
Area of Science:
- Oncology
- Neuroscience
- Pharmacology
Context:
- Advances in carcinoma treatment have extended patient survival.
- Chemotherapy is a cornerstone of cancer treatment.
- Neurotoxicity is a recognized adverse effect of various chemotherapeutic agents.
Purpose:
- To highlight the risk of neurotoxicity associated with chemotherapy.
- To emphasize the specific risk of cisplatin-induced neuropathy.
- To advocate for cautious use of cisplatin in cancer therapy.
Summary:
- Several anticancer drugs, including cisplatin (CDDP), vincristine (VCR), and paclitaxel (PTX), are known to cause polyneuropathy.
- Cisplatin-induced neuropathy is particularly concerning due to its potential for irreversible nerve damage.
- The prolonged survival of carcinoma patients necessitates careful management of treatment side effects like neurotoxicity.
Impact:
- Increased awareness among clinicians regarding chemotherapy-induced neurotoxicity.
- Promotes judicious use of cisplatin to mitigate long-term neurological deficits.
- Contributes to improving the quality of life for cancer survivors by addressing debilitating side effects.
Related Concept Videos
Diabetic Neuropathy
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Antiepileptic Drugs: Glutamate Antagonists